Matthew Hill

5.8k total citations · 1 hit paper
50 papers, 2.1k citations indexed

About

Matthew Hill is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew Hill has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Genetics and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew Hill's work include Genetic Associations and Epidemiology (11 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Matthew Hill is often cited by papers focused on Genetic Associations and Epidemiology (11 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Matthew Hill collaborates with scholars based in United Kingdom, Ireland and Italy. Matthew Hill's co-authors include Julie Williams, Rebecca Sims, Nicholas J. Bray, Gavin P. Reynolds, Katherine E. Tansey, Michael Gill, Richard Anney, Shona L. Kirk, Derek J. Blake and Marc P. Forrest and has published in prestigious journals such as Nature Neuroscience, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Matthew Hill

48 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The multiplex model of the genetics of Alzheimer’s disease

2020 297 citations Rebecca Sims, Matthew Hill et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Hill United Kingdom	24	971	655	347	341	309	50	2.1k
Oksana Kaidanovich‐Beilin Canada	21	1.3k 1.3×	397 0.6×	315 0.9×	523 1.5×	207 0.7×	25	2.4k
Amy Deep‐Soboslay United States	24	1.2k 1.2×	660 1.0×	183 0.5×	458 1.3×	256 0.8×	42	2.2k
Koko Ishizuka United States	21	1.4k 1.4×	431 0.7×	306 0.9×	714 2.1×	218 0.7×	59	2.5k
Alison E. Mungenast United States	20	1.2k 1.2×	443 0.7×	350 1.0×	636 1.9×	137 0.4×	29	2.4k
Qi Xu China	32	1.3k 1.3×	438 0.7×	351 1.0×	637 1.9×	410 1.3×	133	2.9k
Hidenaga Yamamori Japan	29	764 0.8×	529 0.8×	341 1.0×	393 1.2×	638 2.1×	103	2.5k
Michiko Fujimoto Japan	30	1.2k 1.3×	382 0.6×	223 0.6×	641 1.9×	521 1.7×	72	2.7k
Tomoko Toyota Japan	31	1.5k 1.5×	850 1.3×	218 0.6×	818 2.4×	344 1.1×	87	2.8k
Gary W. Beecham United States	24	994 1.0×	565 0.9×	714 2.1×	418 1.2×	181 0.6×	89	2.5k
Rami Abou Jamra Germany	29	1.4k 1.4×	1.1k 1.7×	206 0.6×	544 1.6×	407 1.3×	99	2.8k

Countries citing papers authored by Matthew Hill

Since Specialization

Citations

This map shows the geographic impact of Matthew Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Hill more than expected).

Fields of papers citing papers by Matthew Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Hill. The network helps show where Matthew Hill may publish in the future.

Co-authorship network of co-authors of Matthew Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Hill. A scholar is included among the top collaborators of Matthew Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Hill. Matthew Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Lucy, Geoff Wong, Isla Kuhn, et al.. (2025). A realist review of how, why, for whom and in which contexts quality improvement in healthcare impacts inequalities. BMJ Quality & Safety. 34(8). 537–546.

Howard, Laura, Yuki Ishikawa, Sung‐Joon Park, et al.. (2024). Single-cell transcriptomics reveals the molecular basis of human iPS cell differentiation into ectodermal ocular lineages. Communications Biology. 7(1). 1495–1495. 3 indexed citations

Baker, Emily, Ganna Leonenko, Karl Michael Schmidt, et al.. (2023). What does heritability of Alzheimer’s disease represent?. PLoS ONE. 18(4). e0281440–e0281440. 22 indexed citations

Cameron, Darren, Eilís Hannon, Emma Dempster, et al.. (2021). Sites of active gene regulation in the prenatal frontal cortex and their role in neuropsychiatric disorders. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 186(6). 376–388. 7 indexed citations

Jones, Ruth, Robert Andrews, Peter Holmans, Matthew Hill, & Philip R. Taylor. (2021). Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease. Scientific Reports. 11(1). 14935–14935. 19 indexed citations

Lancaster, T., Matthew Hill, Rebecca Sims, & Julie Williams. (2019). Microglia – mediated immunity partly contributes to the genetic association between Alzheimer’s disease and hippocampal volume. Brain Behavior and Immunity. 79. 267–273. 19 indexed citations

Cameron, Darren, Derek J. Blake, Nicholas J. Bray, & Matthew Hill. (2019). Transcriptional Changes following Cellular Knockdown of the Schizophrenia Risk Gene <b><i>SETD1A</i></b> Are Enriched for Common Variant Association with the Disorder. PubMed. 5(2). 109–114. 8 indexed citations

O’Brien, Heath, Eilís Hannon, Matthew Hill, et al.. (2018). Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders. Genome biology. 19(1). 194–194. 84 indexed citations

Tansey, Katherine E., Darren Cameron, & Matthew Hill. (2018). Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks. Genome Medicine. 10(1). 14–14. 80 indexed citations

10.

Deans, P. J. Michael, Pooja Raval, Katherine J. Sellers, et al.. (2016). Psychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine Structure. Biological Psychiatry. 82(1). 49–61. 67 indexed citations

11.

Forrest, Marc P., Matthew Hill, Andrew J. Quantock, Enca Martin‐Rendon, & Derek J. Blake. (2014). The emerging roles of TCF4 in disease and development. Trends in Molecular Medicine. 20(6). 322–331. 120 indexed citations

12.

Tansey, Katherine E., Matthew Hill, Lynne Cochrane, et al.. (2011). Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism. Molecular Autism. 2(1). 3–3. 68 indexed citations

13.

Quinn, Emma M., Matthew Hill, Richard Anney, et al.. (2010). Evidence for cis‐acting regulation of ANK3 and CACNA1C gene expression. Bipolar Disorders. 12(4). 440–445. 25 indexed citations

14.

Tansey, Katherine E., Keeley J. Brookes, Matthew Hill, et al.. (2010). Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: Genetic and molecular studies. Neuroscience Letters. 474(3). 163–167. 78 indexed citations

15.

Hawi, Ziarih, Lindsey Kent, Matthew Hill, et al.. (2009). ADHD and DAT1: Further evidence of paternal over‐transmission of risk alleles and haplotype. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(1). 97–102. 30 indexed citations

16.

Bromidge, Steven M., Barbara Bertani, Laurie Gordon, et al.. (2008). 6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5653–5656. 23 indexed citations

17.

Scott, Claire M., Ellen M. Soffin, Matthew Hill, et al.. (2006). SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. European Journal of Pharmacology. 536(1-2). 54–61. 13 indexed citations

18.

Reynolds, Gavin P., Matthew Hill, & Shona L. Kirk. (2006). The 5-HT2C receptor and antipsychoticinduced weight gain – mechanisms and genetics. Journal of Psychopharmacology. 20(4_suppl). 15–18. 124 indexed citations

19.

Thomas, David R., Sergio Melotto, Andrew D. Gribble, et al.. (2003). SB‐656104‐A, a novel selective 5‐HT₇ receptor antagonist, modulates REM sleep in rats. British Journal of Pharmacology. 139(4). 705–714. 101 indexed citations

20.

Dizier, Marie‐Hélène, Matthew Hill, Anthony A. James, et al.. (1995). Detection of a recessive major gene for high IgE levels acting independently of specific response to allergens. Genetic Epidemiology. 12(1). 93–105. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact